Lineage (LINE) Stock Price, News & Analysis

Company Overview

Lineage, Inc. is the world's largest global temperature-controlled warehouse REIT with a network of over 480 strategically located facilities totaling over 84.1 million square feet and 3.0 billion cubic feet of capacity across countries in North America, Europe, and Asia-Pacific. Coupling end-to-end supply chain solutions and technology, Lineage partners with some of the world's largest food and beverage producers, retailers, and distributors to help increase distribution efficiency, advance sustainability, minimize supply chain waste, and, most importantly, feed the world.

Key Stats

• Today's Range: $43.92 to $45.69
• 50-Day Range: $42.56 to $56.54
• 52-Week Range: $41.88 to $89.85
• Volume: 1.16 million shs
• Average Volume: 1.21 million shs
• Market Capitalization: $10.08 billion
• P/E Ratio: N/A
• Dividend Yield: 4.79%
• Price Target: $62.10
• Consensus Rating: Hold

Lineage Stock Analysis - MarketRank™

Lineage scored higher than 87% of companies evaluated by MarketBeat, and ranked 194th out of 937 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.2 / 5
• Analyst Rating: Hold

Consensus Rating

Lineage has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 8 buy ratings, 9 hold ratings, and 3 sell ratings.

Amount of Analyst Coverage

Lineage has been the subject of 14 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 36.75%

Earnings Growth

Earnings for Lineage are expected to grow by 36.75% in the coming year, from $2.34 to $3.20 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Lineage is -13.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Lineage is -13.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

Lineage has a PEG Ratio of 4.44. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Lineage has a P/B Ratio of 1.04. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for LINE.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Leadership

Lineage is a leading dividend payer. It pays a dividend yield of 4.79%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Lineage does not have a long track record of dividend growth.

Dividend Sustainability

Based on earnings estimates, Lineage will have a dividend payout ratio of 65.94% next year. This indicates that Lineage will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for LINE.

News and Social Media

• Score: 1.6 / 5
• News Sentiment: -0.10

News Sentiment

Lineage has a news sentiment score of -0.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.90 average news sentiment score of Finance companies.

News Coverage This Week

MarketBeat has tracked 22 news articles for Lineage this week, compared to 13 articles on an average week.

MarketBeat Follows

3 people have added Lineage to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Lineage insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,194,980.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

71.90% of the stock of Lineage is held by insiders. A high percentage of insider ownership can be a sign of company health.

LINE Stock Analysis - Frequently Asked Questions

How have LINE shares performed this year?

Lineage's stock was trading at $58.57 at the start of the year. Since then, LINE stock has decreased by 24.7% and is now trading at $44.09.
View the best growth stocks for 2025 here.

How were Lineage's earnings last quarter?

Lineage, Inc. (NASDAQ:LINE) announced its quarterly earnings results on Wednesday, April, 30th. The company reported $0.86 EPS for the quarter, beating the consensus estimate of $0.82 by $0.04. The company's quarterly revenue was down 2.7% on a year-over-year basis.
Read the conference call transcript.

When did Lineage IPO?

Lineage (LINE) raised $4.4 billion in an initial public offering (IPO) on Thursday, July 25th 2024. The company issued 56,882,051 shares at $78.00 per share.

Who are Lineage's major shareholders?

Lineage's top institutional investors include Vanguard Group Inc. (4.05%), Price T Rowe Associates Inc. MD (1.91%), Baillie Gifford & Co. (1.29%) and Centersquare Investment Management LLC (0.55%). Insiders that own company stock include Adam Matthew Schwartz Forste, Kevin Patrick Marchetti, Robert Crisci, Jeffrey Alvarez Rivera, Sudarsan V Thattai and Abigail S Fleming.
View institutional ownership trends.

How do I buy shares of Lineage?

Shares of LINE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Lineage own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Lineage investors own include Amgen (AMGN), AstraZeneca (AZN), Confluent (CFLT), Halozyme Therapeutics (HALO), Trimble (TRMB), Arch Capital Group (ACGL) and Adobe (ADBE).

Company Calendar

• Record date for 4/21 Dividend: 3/31/2025
• Ex-Dividend for 4/21 Dividend: 3/31/2025
• Dividend Payable: 4/21/2025
• Last Earnings: 4/30/2025
• Today: 6/28/2025
• Record date for 7/21 Dividend: 6/30/2025
• Ex-Dividend for 7/21 Dividend: 6/30/2025
• Dividend Payable: 7/21/2025
• Next Earnings (Estimated): 8/20/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: REIT - EQTY TRUST - OTHER
• Sub-Industry: Trading
• Current Symbol: NASDAQ:LINE
• Previous Symbol: NASDAQ:LINE
• CIK: 1868159
• Web: N/A
• Phone: (800) 678-7271
• Fax: N/A
• Employees: 26,000
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $62.10
• High Stock Price Target: $94.00
• Low Stock Price Target: $42.00
• Potential Upside/Downside: +40.8%
• Consensus Rating: Hold
• Rating Score (0-4): 2.33
• Research Coverage: 21 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($3.22)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 18.84
• P/E Growth: 4.51
• Net Income: -$686 million
• Net Margins: -11.88%
• Pretax Margin: -14.59%
• Return on Equity: -7.24%
• Return on Assets: -3.34%

Debt

• Debt-to-Equity Ratio: 0.66
• Current Ratio: 0.99
• Quick Ratio: 0.86

Sales & Book Value

• Annual Sales: $5.34 billion
• Price / Sales: 1.89
• Cash Flow: $1.00 per share
• Price / Cash Flow: 44.27
• Book Value: $42.33 per share
• Price / Book: 1.04

Miscellaneous

• Outstanding Shares: 228,590,000
• Free Float: 64,234,000
• Market Cap: $10.08 billion
• Optionable: Optionable
• Beta: N/A